【発明の名称】グルカゴン拮抗剤/逆作用剤

Japanese Patent JP2003514508

A

Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof. The compounds act to antagonize the action of the glucagon peptide hormone.

Rin, Anthony
Gregor, Brad
Gonzales, Yavia
Hong, Yuho
Keel, dan
Kuki, Atsuo
Shi, Shenga
Naeram, Lars
Madsen and Peter
Samus, christian
Lau, Jesper
Preve, Michael Bruno
Fen, Jun
Ten, Min
Johnson, Michael David
Teston, Kimberley, Anne
Seidelman, Ulla Grove
Nutsen, Lotte Biere

JP50616099A

April 15, 2003

June 30, 1998

Click for automatic bibliography generation  

Novo Nordisk Actiesel Scab
Agouron Pharmaceuticals Incorporated

C07C251/86; C07C255/29; C07C309/65; C07C311/49; C07C317/28; C07C323/45; C07D209/48; C07D209/86; C07D213/30; C07D213/80; C07D215/12; C07D231/12; C07D295/185; C07D307/12; C07D307/52; C07D309/06; C07D317/58; (IPC1-7): C07C251/80; A61K31/166; A61K31/167; A61K31/18; A61K31/194; A61K31/235; A61K31/27; A61K31/275; A61K31/341; A61K31/351; A61K31/36; A61K31/381; A61K31/40; A61K31/401; A61K31/4035; A61K31/404; A61K31/4045; A61K31/421; A61K31/426; A61K31/433; A61K31/437; A61K31/438; A61K31/44; A61K31/4409; A61K31/443; A61K31/4436; A61K31/445; A61K31/4468; A61K31/454; A61K31/47; A61K31/472; A61K31/4725; A61K31/495; A61K31/496; A61K31/506; A61K31/5375; A61K31/5377; A61K31/541; A61P1/00; A61P1/18; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P9/04; A61P43/00; C07C251/86; C07C255/13; C07C255/57; C07C311/49; C07C317/18; C07C317/28; C07C317/44; C07D207/08; C07D207/09; C07D207/14; C07D207/16; C07D209/14; C07D209/16; C07D209/48; C07D209/86; C07D211/14; C07D211/16; C07D211/22; C07D211/28; C07D211/52; C07D211/58; C07D211/60; C07D211/62; C07D211/66; C07D211/70; C07D213/30; C07D213/38; C07D213/40; C07D213/74; C07D213/80; C07D213/81; C07D215/48; C07D217/04

Takehiko Suzue (4 outside)

Previous Patent: センサレス及びブラシレス直流モータの始動方法

Next Patent: 多分化機能性細胞−２